Precision Biosciences hoping to raise $100 million through an IPO
DURHAM A biotechnology company based in downtown Durham has filed plans to go public — a move that could net the company around $100 million. Precision BioSciences, which has offices at the historic Venable Center…
Off-the-shelf CAR-T and gene-editing player Precision Bio files $100M IPO
Precision BioSciences is looking to raise up to $100 million in an IPO just a few months after raising $110 million in a series B and bagging a hepatitis B alliance with Gilead. The Durham, North…
PhaseBio Announces Acceptance of Late-Breaking Clinical Trial Submission of PB2452
PhaseBio Announces Acceptance of Late-Breaking Clinical Trial Submission of PB2452 Phase 1 Clinical Trial Results for Presentation at the American College of Cardiology’s 68th Annual Scientific Session Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused…
2019 Edward Novitski Prize awarded to Joseph Heitman
Joseph Heitman, MD, PhD of Duke University is the recipient of the 2019 Genetics Society of America (GSA) Edward Novitski Prize. Heitman is honored for his work on human fungal pathogens and for identifying the molecular targets of…
Duke Among Top 10 for Federal Medical Research Funding
Duke University received $384.6 million last year from the National Institutes of Health to advance medical research, ranking 9th in the country among universities, research institutions and teaching hospitals that are awarded the taxpayer-based research…
Using Supercomputers to Checkmate Cancer
Unless they’ve had a family member with cancer, most people don’t know that cancer cells mutate rapidly to escape the drugs we use to kill them. Duke PhD student Marcel Frenkel knows this problem well,…
‘Tumour Monorail’ on Fast Track for Human Trials
Pioneering device for treating cancers lures tumour cells out of the brain Pied Piper-style. A biomedical device designed to lure tumour cells out of the brain Pied Piper-style has been awarded specialist breakthrough status by…
Showcasing Innovation at 2nd “Invented at Duke” Celebration
From Antiperspirant Lotion To Waste Treatment To Targeted Radiotherapy – Duke Made Yet Another Exhibition Of Ingenious Innovations That Span Numerous Fields And Applications. Riding on the success of the first “Invented at Duke” event…
Duke Celebrates Innovation & Entrepreneurship at 1st Annual “Invented at Duke”
“Commercialization turns discovery into invention, enabling Duke researchers to fulfill our institution’s mission of bringing knowledge to bear in service to society.” –President Price A puncture-proof vascular graft, silicone microspheres, improved eye disease imaging, a…